Bayer shares fall amid cancer scandal
------------------------
Adverse jury verdicts have wiped more than 40% from Bayer’s market value since August 2018, with the German pharmaceutical group ordered to pay damages over its glyphosate-based weedkillers
------------------------
Jun 7, 2018: Bayer acquires glyphosate-based Roundup and RangerPro herbicides as part of $63bn takeover of U.S. chemical rival Monsanto
------------------------
Aug 10: San Francisco state court orders Monsanto to pay $289m damages – later reduced to $78m – to man who claimed glyphosate herbicides caused his cancer
------------------------
Mar 19, 2019: California jury orders Bayer to pay $80m in damages to cancer patient exposed to Roundup
------------------------
May 13: Elderly couple who claim Roundup caused their cancers awarded $2bn in damages – highest award to date in escalating legal battle
------------------------
Werner Baumann
Bayer chief executive, architect of Monsanto deal, under pressure as group faces over 13,400 U.S. lawsuits over alleged cancer risks
------------------------
BAYER AG share price

€100 €90 €80 €70 €60 €50

Jul Sep Nov Jan Mar May

€98.94  €93.36 €69.70 €56.53                    

2018    2019
------------------------
Sources: www.investor.bayer.com, FT, Reuters Picture: Getty Images © GRAPHIC NEWS